Zosano Pharma to Report Fourth Quarter and 2015 Financial Results and to Provide a Corporate Update
March 21, 2016 08:30 ET
|
Zosano Pharma Corporation
FREMONT, Calif., March 21, 2016 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) today announced that it plans to report financial results for the fourth quarter and full year 2015 on...
Zosano Pharma to Present at the 28th Annual ROTH Conference
March 09, 2016 08:00 ET
|
Zosano Pharma Corporation
FREMONT, Calif., March 09, 2016 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage specialty pharmaceutical company, today announced that Konstantinos Alataris, Ph.D.,...
Zosano Pharma Announces Appointment of Konstantinos Alataris, Ph.D. as President and Chief Executive Officer
January 07, 2016 16:05 ET
|
Zosano Pharma Corporation
FREMONT, Calif., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage pharmaceutical company, today announced the appointment of Konstantinos Alataris, Ph.D....
Zosano Pharma Reports Third Quarter 2015 Financial Results
November 09, 2015 16:01 ET
|
Zosano Pharma Corporation
FREMONT, Calif., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage specialty pharmaceutical company, today announced financial results for the three...
Zosano Pharma to Announce Third Quarter 2015 Financial Results, Host Conference Call and Live Webcast on November 9, 2015
November 03, 2015 08:00 ET
|
Zosano Pharma Corporation
FREMONT, Calif., Nov. 03, 2015 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage specialty pharmaceutical company, announced today that it will release its...
Zosano Pharma Announces Positive Phase 1 Results for Its ZP-Triptan Patch Program for Treatment of Migraine
November 02, 2015 16:05 ET
|
Zosano Pharma Corporation
FREMONT, Calif., Nov. 02, 2015 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage specialty pharmaceutical company, today announced positive results from the Phase 1...
Zosano Pharma Announces Positive Phase 2 Results for Its ZP-Glucagon Patch Program for Treatment of Severe Hypoglycemia
October 13, 2015 08:30 ET
|
Zosano Pharma Corporation
FREMONT, Calif., Oct. 13, 2015 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage specialty pharmaceutical company, today announced positive results from the Phase 2...